Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane EC50 for Immobility in Cerebral Palsy Children
NCT03553446Completed
- Sponsor
- Yeungnam University College of Medicine
- Start
- Jul 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sevoflurane in cerebral palsy (CP), sponsored by Yeungnam University College of Medicine. Primary endpoint: The incidence of immobility. Started Jul 2018; status: completed.
02
Drugs
sevoflurane
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03553446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553446.